Any early-onset non-syndromic cataract in which the cause of the disease is a mutation in the LIM2 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation on cataract 19 is limited primarily because it affects a small population, making systematic clinical studies challenging. Additionally, the genetic basis was identified relatively recently, and ongoing research is needed to fully characterize the clinical features and variability of this condition. This can understandably lead to frustration for those affected, as comprehensive resources are not yet available.
To navigate your care effectively, consider seeking a geneticist or an ophthalmologist with experience in hereditary cataracts. Genetic counseling can provide insights into family planning and the implications of the LIM2 mutation. While there are no patient organizations specifically for cataract 19, you can find resources through the National Organization for Rare Disorders (NORD) at [rarediseases.org](https://rarediseases.org). Additionally, inquire about any natural history studies or registries that might be available for individuals with cataracts caused by genetic mutations.
Currently, there is one active clinical trial related to cataract 19. While there are no orphan drug designations or approved treatments, the existence of this trial indicates ongoing research efforts. You can explore participation opportunities through the following link: [ClinicalTrials.gov](https://clinicaltrials.gov/search?cond=cataract%2019%20multiple%20types). This could be a valuable avenue for accessing potential new therapies and contributing to the understanding of this condition.
Actionable guidance for navigating care for cataract 19 multiple types
To navigate your care effectively, consider seeking a geneticist or an ophthalmologist with experience in hereditary cataracts. Genetic counseling can provide insights into family planning and the implications of the LIM2 mutation. While there are no patient organizations specifically for cataract 19, you can find resources through the National Organization for Rare Disorders (NORD) at [rarediseases.org](https://rarediseases.org). Additionally, inquire about any natural history studies or registries that might be available for individuals with cataracts caused by genetic mutations.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on cataract 19 is limited primarily because it affects a small population, making systematic clinical studies challenging. Additionally, the genetic basis was identified relatively recently, and ongoing research is needed to fully characterize the clinical features and variability of this condition. This can understandably lead to frustration for those affected, as comprehensive resources are not yet available.
To navigate your care effectively, consider seeking a geneticist or an ophthalmologist with experience in hereditary cataracts. Genetic counseling can provide insights into family planning and the implications of the LIM2 mutation. While there are no patient organizations specifically for cataract 19, you can find resources through the National Organization for Rare Disorders (NORD) at [rarediseases.org](https://rarediseases.org). Additionally, inquire about any natural history studies or registries that might be available for individuals with cataracts caused by genetic mutations.
Currently, there is one active clinical trial related to cataract 19. While there are no orphan drug designations or approved treatments, the existence of this trial indicates ongoing research efforts. You can explore participation opportunities through the following link: [ClinicalTrials.gov](https://clinicaltrials.gov/search?cond=cataract%2019%20multiple%20types). This could be a valuable avenue for accessing potential new therapies and contributing to the understanding of this condition.
Actionable guidance for navigating care for cataract 19 multiple types
To navigate your care effectively, consider seeking a geneticist or an ophthalmologist with experience in hereditary cataracts. Genetic counseling can provide insights into family planning and the implications of the LIM2 mutation. While there are no patient organizations specifically for cataract 19, you can find resources through the National Organization for Rare Disorders (NORD) at [rarediseases.org](https://rarediseases.org). Additionally, inquire about any natural history studies or registries that might be available for individuals with cataracts caused by genetic mutations.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on cataract 19 is limited primarily because it affects a small population, making systematic clinical studies challenging. Additionally, the genetic basis was identified relatively recently, and ongoing research is needed to fully characterize the clinical features and variability of this condition. This can understandably lead to frustration for those affected, as comprehensive resources are not yet available.
To navigate your care effectively, consider seeking a geneticist or an ophthalmologist with experience in hereditary cataracts. Genetic counseling can provide insights into family planning and the implications of the LIM2 mutation. While there are no patient organizations specifically for cataract 19, you can find resources through the National Organization for Rare Disorders (NORD) at [rarediseases.org](https://rarediseases.org). Additionally, inquire about any natural history studies or registries that might be available for individuals with cataracts caused by genetic mutations.
Currently, there is one active clinical trial related to cataract 19. While there are no orphan drug designations or approved treatments, the existence of this trial indicates ongoing research efforts. You can explore participation opportunities through the following link: [ClinicalTrials.gov](https://clinicaltrials.gov/search?cond=cataract%2019%20multiple%20types). This could be a valuable avenue for accessing potential new therapies and contributing to the understanding of this condition.
Actionable guidance for navigating care for cataract 19 multiple types
To navigate your care effectively, consider seeking a geneticist or an ophthalmologist with experience in hereditary cataracts. Genetic counseling can provide insights into family planning and the implications of the LIM2 mutation. While there are no patient organizations specifically for cataract 19, you can find resources through the National Organization for Rare Disorders (NORD) at [rarediseases.org](https://rarediseases.org). Additionally, inquire about any natural history studies or registries that might be available for individuals with cataracts caused by genetic mutations.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.